Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets
Abstract Background The Placebo Group Simulation Approach (PGSA) aims at partially replacing randomized placebo-controlled trials (RPCTs), making use of data from historical control groups in order to decrease the needed number of study participants exposed to lengthy placebo treatment. PGSA algorit...
Main Authors: | Manfred Berres, Andreas U. Monsch, René Spiegel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-021-00832-5 |
Similar Items
-
The Use of EEG and ERPs in the Study of Aging and Mild Cognitive Impairment (MCI)
by: Kamal, Farooq
Published: (2021) -
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
by: Andrea Brugnolo, et al.
Published: (2021-01-01) -
The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
by: Ye Tao, et al.
Published: (2020-04-01) -
Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
by: Daniela Bertens, et al.
Published: (2019-08-01) -
Incidence and predictors of mild cognitive impairment (MCI) within a multi-ethnic Asian populace: a community-based longitudinal study
by: Norlela Mohd Hussin, et al.
Published: (2019-08-01)